Crispr Therapeutics AG (0VRQ)
Market Closed
3 Mar, 15:30
LSE 
$
57. 44
-2.55
-4.25%
$
- Market Cap
- P/E Ratio
- Div Yield
5,206 Volume
-2.71 Eps
$ 59.99
Previous Close Day Range
56.06 59.04
Year Range
30.04 78.47
Want to track 0VRQ and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
0VRQ earnings report is expected in 69 days (11 May 2026)
0VRQ Earnings Reports FAQ
What is the earnings per share (EPS) for 0VRQ?
The current EPS is -2.71.
What is the company's earnings growth rate?
Crispr Therapeutics AG has not announced its next earnings release date. You can monitor upcoming announcements in Marketlog's earnings calendar or in the company profile.
When is the next earnings release date?
The next earnings release is expected to be on 2026-05-11, based on the 0VRQ's typical earnings announcement schedule.
What were the most recent quarterly earnings?
The most recent quarterly earnings for Crispr Therapeutics AG are not available at this time.
What is the price-to-earnings (P/E) ratio?
There is no P/E ratio for 0VRQ at this time, as Crispr Therapeutics AG has no recent EPS data to calculate it.
